Related Experiment Videos

Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis

W E Samlowski1, C Y Yim, J R McGregor

  • 1Cancer Immunotherapy Program, Huntsman Cancer Institute, Salt Lake City, Utah, USA. wolfs@crc-gw.med.utah.edu

Insights

Nitric oxide (NO) inhibits the development of lymphokine-activated killer (LAK) cells by inducing programmed cell death in lymphocyte precursors. This finding suggests NO may suppress anti-tumor immunity during IL-2 therapy.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Interleukin-2 (IL-2) therapy induces nitric oxide (NO) synthesis.
  • NO can have anti-tumor effects but also potential immunosuppressive roles.

Purpose of the Study:

  • To investigate the impact of NO exposure on the induction of murine lymphokine-activated killer (LAK) cells.
  • To determine if NO affects LAK cell cytotoxicity, proliferation, or survival.

Main Methods:

  • Splenocytes were exposed to NO gas before IL-2 stimulation.
  • LAK cell cytotoxicity, proliferation (concanavalin A or IL-2), and subset populations (CD8+, PNA+/CD56+) were assessed.
  • Apoptosis was detected using DNA strand break staining.

Main Results:

  • Pre-treatment with NO completely abrogated LAK cell induction.
  • NO exposure minimally affected established LAK cell cytotoxicity but reduced proliferation.
  • NO induced apoptosis in CD8+ and PNA+/CD56+ lymphocyte precursors.

Conclusions:

  • NO inhibits LAK cell induction by triggering apoptosis in precursor cells.
  • NO exposure can impair the development of crucial anti-tumor immune cells.

Related Concept Videos